{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:31:56Z","timestamp":1789122716807,"version":"build-2803163510"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41409-026-02967-1","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T11:42:28Z","timestamp":1783338148000},"page":"1283-1285","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epigenetic priming with azacitidine-BEAM versus decitabine-BEAM conditioning for autologous transplantation in non-Hodgkin\u2019s lymphoma"],"prefix":"10.1038","volume":"61","author":[{"given":"Jiajie","family":"Tu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Ping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danqing","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingzi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Depei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengming","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1803-0008","authenticated-orcid":false,"given":"Changju","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"2967_CR1","first-page":"404","volume":"27","author":"L Zhang","year":"2022","unstructured":"Zhang L, Yang H, Qian C, Zhou J, Zhu Q, Jiang Y, et al. Efficacy and toxicity of SEAM (semustine, etoposide, cytarabine, and melphalan) conditioning regimen followed by autologous stem cell transplantation in lymphoma. Hematol Amst Neth. 2022;27:404\u201311.","journal-title":"Hematol Amst Neth"},{"key":"2967_CR2","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1038\/s41409-019-0463-y","volume":"54","author":"S Singer","year":"2019","unstructured":"Singer S, Sharma N, Dean R, Zhao Q, Abounader D, Elder P, et al. BEAM or BUCYVP16-conditioning regimen for autologous stem-cell transplantation in non-Hodgkin\u2019s lymphomas. Bone Marrow Transpl. 2019;54:1553\u201361.","journal-title":"Bone Marrow Transpl"},{"key":"2967_CR3","doi-asserted-by":"publisher","first-page":"602","DOI":"10.52586\/4970","volume":"26","author":"M-K Liu","year":"2021","unstructured":"Liu M-K, Sun X-J, Gao X-D, Qian Y, Wang L, Zhao W-L. Methylation alterations and advance of treatment in lymphoma. Front Biosci Landmark Ed. 2021;26:602\u201313.","journal-title":"Front Biosci Landmark Ed"},{"key":"2967_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7921","volume":"6","author":"H Pan","year":"2015","unstructured":"Pan H, Jiang Y, Boi M, Tabb\u00f2 F, Redmond D, Nie K, et al. Epigenomic evolution in diffuse large B-cell lymphomas. Nat Commun. 2015;6:6921.","journal-title":"Nat Commun"},{"key":"2967_CR5","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1158\/2159-8290.CD-13-0117","volume":"3","author":"T Clozel","year":"2013","unstructured":"Clozel T, Yang S, Elstrom RL, Tam W, Martin P, Kormaksson M, et al. Mechanism-based epigenetic chemosensitization therapy of diffuse large B-cell lymphoma. Cancer Discov. 2013;3:1002\u201319.","journal-title":"Cancer Discov"},{"key":"2967_CR6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/ijc.70197","volume":"158","author":"V Wenger","year":"2026","unstructured":"Wenger V, Garcia-Manero G, Zeiser R, L\u00fcbbert M. DNA methyltransferase inhibitors in hematological malignancies and solid tumors. Int J Cancer. 2026;158:433\u201361.","journal-title":"Int J Cancer"},{"key":"2967_CR7","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/sj.bmt.1700913","volume":"20","author":"M Caballero","year":"1997","unstructured":"Caballero M, Rubio V, Rifon J, Heras I, Garc\u00eda-Sanz R, V\u00e1zquez L, et al. BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors. Bone Marrow Transpl. 1997;20:451\u20138.","journal-title":"Bone Marrow Transpl"},{"key":"2967_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2025.102594","volume":"63","author":"H Tian","year":"2025","unstructured":"Tian H, Wang R, Cong D, Bai Y, Zhang W. Evolution of conditioning regimens prior to autologous stem cell transplantation in lymphoma patients. Transl Oncol. 2025;63:102594.","journal-title":"Transl Oncol"},{"key":"2967_CR9","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.bbmt.2015.02.005","volume":"21","author":"Y-B Chen","year":"2015","unstructured":"Chen Y-B, Lane AA, Logan B, Zhu X, Akpek G, Aljurf M, et al. Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation. Biol Blood Marrow Transpl. 2015;21:1046\u201353.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2967_CR10","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1182\/blood.2021015019","volume":"140","author":"TA Herek","year":"2022","unstructured":"Herek TA, Bouska A, Lone W, Sharma S, Amador C, Heavican TB, et al. DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS. Blood. 2022;140:1278\u201390.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02967-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02967-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02967-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T09:37:35Z","timestamp":1789119455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02967-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2967"],"URL":"https:\/\/doi.org\/10.1038\/s41409-026-02967-1","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"26 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Ethical approval was obtained from the patient for the publication of any potentially identifiable data included in this article. This study was approved by the Medical Ethics Committee of the First Affiliated Hospital of Soochow University (2026316). All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}